Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00495677
Status:
COMPLETED
Last Update Posted:
2013-10-30
First Post:
2007-06-29
Brief Title:
A Phase 2 Study Of PF-00232798 In HIV Positive Patients
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Randomised Double-Blind Placebo-Controlled Multicentre Study In Asymptomatic Hiv-Infected Patients To Investigate The Pharmacodynamics Pharmacokinetics Safety And Toleration Of PF-00232798
Status:
COMPLETED
Status Verified Date:
2013-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the viral load response safety tolerability and pharmacokinetics of multiple oral doses of PF 00232798 in HIV-positive patient volunteers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None